Yestar Healthcare Holdings Co Ltd

As of December 31, 2025, Yestar Healthcare Holdings Co Ltd carries a market capitalization of 235.49M, placing it among publicly traded companies globally. Its enterprise value stands at 218.05M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Yestar Healthcare Holdings Co Ltd's next confirmed earnings release is scheduled for March 26, 2027.

As of December 31, 2025, Yestar Healthcare Holdings Co Ltd has 2.33B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Yestar Healthcare Holdings Co Ltd maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Yestar Healthcare Holdings Co Ltd's stock has declined approximately 53.24% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.09.

As of December 31, 2025, Yestar Healthcare Holdings Co Ltd holds 285.19M in cash and equivalents against 234.78M in total debt, resulting in a net debt position of -54.22M. Total book value stands at 420.78M, with working capital of 275.67M providing operational flexibility.

Yestar Healthcare Holdings Co Ltd's most recent stock split took place on January 2, 2015 with a 1:4 split ratio.